Clinical Trial Update: Two Formulations and Concentrations of Epinastine Nasal Spray Versus Azelastine Nasal Solution for Allergic Rhinitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial compared two epinastine nasal spray formulations with azelastine nasal solution for allergic rhinitis. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Azelastine nasal solution (azelastine)
• Epinastine nasal spray (formulation 1) (epinastine)
• Epinastine nasal spray (formulation 2) (epinastine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Allergic Rhinitis | Phase 2 | Status: COMPLETED